Abstract
Background: It is widely accepted that histological diagnosis of parathyroid tumors is established with great difficulty. Carcinomas cannot be reliably separated from adenomas by histology alone. In this study, immunohistochemical staining for proliferating cell nuclear antigen (PCNA) and Ki-67 was determined in 10 cases of parathyroid carcinomas, labeling indices (LIs) were calculated, and the results were correlated with the clinical outcomes.
Methods: Ten cases of formalin-fixed, paraffin-embedded tissue with surgically resected parathyroid carcinoma were used. Immunohistochemical staining for PCNA and Ki-67 was performed and the LIs were calculated. We also examined whether LI could become a useful marker for parathyroid carcinomas.
Results: Although nine patients with minimally invasive growth without recurrence of the tumor showed a low LI for both markers, one patient with a widely invasive neoplasm, and who died, had a high LI.
Conclusions: These results suggested that the LI of PCNA and Ki-67, in addition to the histological appearance, may be markers of the biological behavior of parathyroid carcinomas. However, this study was on a small scale, so it may be valuable to repeat these studies in a larger group of patients with better defined histological criteria.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Matthews MB, Berstein RM, Franza BR Jr, Garrels JI. Identify of the proliferating cell nuclear antigen and cyclin. Nature 1984;303: 374–376.
Garcia RL, Coltrera MD, Gown AM. Analysis of proliferative grade using anti-PCNA-cyclin monoclonal antibodies in fixed, embedded tissues: comparison with flow cytometric analysis. Am J Pathol 1989;134:733–739.
Cattoretti G, Becker MHG, Key G, et al. Monoclonal antibodies against recombinant part of the ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in micro-wave processed formalin-fixed paraffin sections. J Pathol 1992;168:357–363.
Gerdes J, Lemke H, Baisch H, Wackes HH, Schwab V, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984;133:1710–1715.
Bondeson L, Sandelin K, Grimelius L. Histopathological variables and DNA cytometry in parathyroid carcinoma. Am J Surg Pathol 1993;17:820–829.
Abbona GC, Papotti M, Gasparri G, Bussolati G. Proliferative activity in parathyroid tumors as detected by Ki-67 immunostaining. Hum Pathol 1995;26:135–138.
Lloyd RV, Carney JA, Ferreiro JA, et al. Immunohistochemical analysis of the cell cycle-associated antigen Ki-67 and retinoblastoma protein in parathyroid carcinomas and adenomas. Endocr Pathol 1995;4:279–287.
Naccarato AG, Marcocci C, Miccoli P, et al. Bcl-2, p53 and MIB-1 expression in normal and neoplastic parathyroid tissue. J Endocrinol Invest 198;21:136–141.
Cryns VL, Thor A, Xu HJ, et al. Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma. N Engl J Med 1994; 330:757–761.
Farnebo F, Auer G, Farnebo L-O, et al. Evaluation of retinoblastoma and Ki-67 immunostaining as diagnostic markers of benign and malignant parathyroid disease. World J Surg 1999; 23:68–74.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kameyama, K., Takami, H., Umemura, S. et al. PCNA and Ki-67 as Prognostic Markers in Human Parathyroid Carcinomas. Ann Surg Oncol 7, 301–305 (2000). https://doi.org/10.1007/s10434-000-0301-9
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10434-000-0301-9